|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.
The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by Cowen & Co. on August 13, 2021. The analyst firm set a price target for 0.00 expecting TCRX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $8 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for TScan Therapeutics. The last dividend paid out to investors was $0.07 on June 14, 2018.
TScan Therapeutics’s $Q3 earnings are confirmed for after-market on $November 19, 2021.
There is no upcoming split for TScan Therapeutics.
TScan Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.